drugset / Trial / NCT03330184

Summary

The aim of this study is to assess the beneficial effects of Bifidobacterium and Berberine Hydrochloride on lowering glucose and delaying progress to diabetes in patients with prediabetes and to detect the potential mechanism.

Timeline

Start
2015-10
Primary completion
2018-04
Completion
2018-04

Outcome

Met primary endpoint

paper Significant reductions of FPG were observed in the Be and BB groups compared with the placebo group PMID 34365978 ↗

paper with a least square (LS) mean difference of - 0.50, 95% CI [- 0.85, - 0.15] mmol/L PMID 34365978 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject BIFIDOBACTERIUM SPP. Other / unclassified — —
Subject Berberine Traditional medicine (herbal / TCM) — —

Indications

No indication recorded.